Aspen Aerogels (NYSE:ASPN) Raised to Hold at Zacks Research

by · The Cerbat Gem

Aspen Aerogels (NYSE:ASPN – Get Free Report) was upgraded by equities research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Thursday,Zacks.com reports.

A number of other brokerages have also issued reports on ASPN. Canaccord Genuity Group decreased their target price on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Barclays decreased their price objective on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a report on Friday, November 7th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, three have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $12.67.

Get Our Latest Stock Analysis on Aspen Aerogels

Aspen Aerogels Stock Performance

Shares of ASPN stock opened at $3.48 on Thursday. Aspen Aerogels has a 12-month low of $2.80 and a 12-month high of $12.90. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33. The firm has a market capitalization of $287.62 million, a price-to-earnings ratio of -0.94 and a beta of 2.94. The business has a 50 day simple moving average of $3.20 and a 200 day simple moving average of $5.83.

Aspen Aerogels (NYSE:ASPN – Get Free Report) last announced its earnings results on Thursday, November 6th. The construction company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.05). Aspen Aerogels had a negative net margin of 86.52% and a negative return on equity of 0.20%. The business had revenue of $73.02 million for the quarter, compared to the consensus estimate of $73.42 million. During the same period in the previous year, the firm earned ($0.17) EPS. The firm’s revenue was down 37.8% on a year-over-year basis. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. On average, equities research analysts anticipate that Aspen Aerogels will post 0.17 EPS for the current year.

Insider Activity at Aspen Aerogels

In other news, CEO Donald R. Young sold 56,845 shares of the firm’s stock in a transaction on Thursday, November 13th. The stock was sold at an average price of $3.23, for a total transaction of $183,609.35. Following the completion of the sale, the chief executive officer directly owned 494,011 shares of the company’s stock, valued at $1,595,655.53. This trade represents a 10.32% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 4.30% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of ASPN. Gagnon Securities LLC acquired a new stake in shares of Aspen Aerogels in the 2nd quarter valued at about $11,243,000. Y Intercept Hong Kong Ltd acquired a new stake in Aspen Aerogels in the 2nd quarter valued at approximately $484,000. Palogic Value Management L.P. lifted its stake in Aspen Aerogels by 43.5% in the 2nd quarter. Palogic Value Management L.P. now owns 610,000 shares of the construction company’s stock valued at $3,611,000 after acquiring an additional 185,000 shares in the last quarter. SG Americas Securities LLC boosted its position in Aspen Aerogels by 98.6% during the 2nd quarter. SG Americas Securities LLC now owns 133,821 shares of the construction company’s stock worth $792,000 after acquiring an additional 66,427 shares during the last quarter. Finally, Federated Hermes Inc. acquired a new stake in shares of Aspen Aerogels in the second quarter valued at approximately $10,459,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

Further Reading